In recent years, the management of diabetes has evolved significantly, with the introduction of various medications aimed at improving blood sugar control. Among these medications, Zepbound and Trulicity have emerged as popular choices for patients and healthcare providers. Both drugs belong to the class of glucagon-like peptide-1 (GLP-1) receptor agonists, which have shown effectiveness in managing type 2 diabetes. The increasing prevalence of diabetes worldwide has led to a surge in interest surrounding these medications, as individuals seek effective and efficient solutions to maintain their health and well-being. Understanding the differences and similarities between Zepbound and Trulicity can help patients and caregivers make informed decisions about their diabetes management options.…